Which of the following contrast agents is preferred in a patient with decreased renal function to avoid contrast nephropathy –
**Core Concept**
Iodinated contrast agents are commonly used in medical imaging procedures, but their use can be associated with contrast-induced nephropathy (CIN), particularly in patients with pre-existing renal dysfunction. The kidneys play a crucial role in the excretion of iodinated contrast agents, and decreased renal function can impair this process, leading to the accumulation of contrast agents in the kidneys and potentially causing damage.
**Why the Correct Answer is Right**
Iohexol is a non-ionic, low-osmolar contrast agent that is preferred in patients with decreased renal function because it has a lower risk of causing CIN compared to high-osmolar contrast agents. Iohexol is primarily excreted by the kidneys, and its lower osmolality and non-ionic nature make it less likely to cause renal vasoconstriction and oxidative stress, which are thought to contribute to the development of CIN. Additionally, iohexol has a lower molecular weight compared to other contrast agents, which allows for faster and more efficient excretion by the kidneys.
**Why Each Wrong Option is Incorrect**
**Option A:** Iopamidol is an ionic, low-osmolar contrast agent that is not as preferred in patients with decreased renal function as iohexol. Although it has a lower osmolality compared to high-osmolar contrast agents, its ionic nature can still cause renal vasoconstriction and oxidative stress, increasing the risk of CIN.
**Option B:** Ioversol is a non-ionic, high-osmolar contrast agent that is not preferred in patients with decreased renal function due to its higher risk of causing CIN. Its high osmolality can cause renal vasoconstriction and oxidative stress, which can lead to renal damage.
**Option C:** Iodixanol is a non-ionic, iso-osmolar contrast agent that is not as preferred in patients with decreased renal function as iohexol. Although it has a similar osmolality to blood, its molecular weight is higher than iohexol, which can slow down its excretion by the kidneys.
**Clinical Pearl / High-Yield Fact**
When choosing a contrast agent in patients with decreased renal function, it's essential to consider the agent's osmolality, ionic nature, and molecular weight to minimize the risk of CIN. Iohexol is a preferred choice due to its low osmolality and non-ionic nature, which make it less likely to cause renal vasoconstriction and oxidative stress.
**Correct Answer:** C. Iohexol.